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Abstract
Background:  Abnormalities in limbic structures have been implicated in major depressive
disorder (MDD). Although MDD is as common in adolescence as in adulthood, few studies have
examined youth near illness onset in order to determine the possible influence of atypical
development on the pathophysiology of this disorder.
Methods: Hippocampal volumes were measured in 17 MDD subjects (age = 16.67 ± 1.83 years
[mean ± SD]; range = 13 – 18 years) and 17 age- and sex-matched healthy controls (16.23 ± 1.61
years [mean ± SD]; 13 – 18 years) using magnetic resonance imaging (MRI).
Results: An analysis of covariance revealed a significant difference between MDD and control
subjects (F = 8.66, df = 1, 29, P = 0.006). This was more strongly localized to the left hippocampus
(P = 0.001) than the right hippocampus (P = 0.047).
Conclusions: Our findings provide new evidence of abnormalities in the hippocampus in early
onset depression. However, our results should be considered preliminary given the small sample
size studied.
Background
Major depressive disorder (MDD) is a severe, common
and debilitating illness with alarming rates of morbidity
and mortality. Evidence suggests that child and adolescent
MDD is continuous with adult MDD [1]. The lifetime
prevalence of MDD in youth is approximately 15 – 20 %,
which is consistent with adult rates of MDD [1].
Structural neuroimaging studies in adult MDD have
explored the role of prefrontal cortex, basal ganglia and
temporal limbic circuitry in the pathophysiology of the
disorder [2]. In the hippocampus, studies of adult MDD
have yielded mixed results, with some studies noting
smaller volumes [3-11] while five studies failed to note
significant differences in hippocampal volumes in adults
with depression [12-16]. As noted by Sheline [17], the
majority of the studies that reported negative results uti-
lized a lower level of magnetic resonance imaging (MRI)
resolution than the studies that had positive findings, and
this difference in acquisition may have contributed to the
divergent findings.
Few studies have examined brain structure in youth with
MDD using MRI techniques [18]. Here, we examined hip-
pocampal volume using MRI in adolescents with MDD
and age- and sex-matched healthy controls. Studies of
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younger patients with MDD near illness onset are critical
in our efforts to delineate the pertinent neurobiological
substrates of the disorder and to minimize the confounds
of course of illness and treatment intervention.
Methods
Subjects
Seventeen subjects with MDD aged 13 to 18 years (8
males and 9 females) and 17 healthy controls matched
pairwise for age and sex were recruited. The age of onset of
the first clinical presentation in the patients with MDD
was 14.06 ± 1.98 years (mean ± SD). Duration of illness
in the MDD subjects was 2.89 ± 1.71 years. All case-con-
trol pairs were matched within 12 months of each other.
Patients were recruited after being referred to the Izaak
Walton Killam (IWK) Health Center's department of Psy-
chiatry. Controls were garnered through advertisement.
Both patients and controls were paid a small honorarium
for their participation in the study. The Schedule for Affec-
tive Disorders and Schizophrenia for School-Age Chil-
dren-Present Lifetime version (K-SADS-PL [19]) was used
to establish diagnosis. Exclusion criteria for participation
in this study were a history of neurological illness, serious
medical illness, claustrophobia, age greater than 18 years,
or the presence of a ferrous implant or pacemaker.
Depression symptom severity was assessed using the
Childhood Depression Rating Scale [20] (CDRS; score =
65.35 ± 13.87 [mean ± SD]). All depressed subjects had a
CDRS score above 42, indicative of significant dysfunc-
tion. Nine MDD subjects had a family history of a mood
disorder. Two subjects had a comorbid diagnosis of sub-
stance abuse and one subject had comorbid diagnosis of
oppositional defiant disorder. Three MDD subjects had
recently started medication (sertraline, methylphenidate
and zopiclone). The remainder of the MDD subjects was
treatment naïve (n = 14). Controls did not have any psy-
chiatric illness. Controls were also screened for depression
with the CDRS (score = 40.35 ± 13.69 [mean ± SD]). Writ-
ten informed consent was obtained prior to initiating the
study in compliance with the IWK Research Ethics Board.
MRI data acquisition
The MRI studies were conducted with a 1.5 Tesla Siemens
Magnetom Vision magnetic resonance system (Germany).
A sagittal scout series was acquired to test image quality. A
three-dimensional fast low angle shot (FLASH) sequence
was used to acquire data from 124 1.5-mm thick contigu-
ous coronal slices through the entire brain (echo time = 5
ms, repetition time = 25 ms, acquisition matrix = 256 ×
256 pixels, field of view = 24 cm and flip angle = 40°).
Positioning was done in a standardized manner in order
to ensure consistency of acquisitions. Images were
exported to a computer workstation (Macintosh G4,
Apple Computer, Cupertino, California).
Image analysis
Anatomical boundaries were determined from neuroana-
tomical atlases [21,22]. Anatomical data were analyzed
using National Institutes of Health Imaging software
(NIHImage 1.62), a semi-automated segmentation algo-
rithm for obtaining reliable quantitative neuroanatomical
measurements [23]. Mathematical cutoffs for gray matter-
white matter-cerebral spinal fluid divisions were deter-
mined with histograms of signal intensity. A point count-
ing stereological approach based on the Cavalieri theorem
of systematic sampling has validated this method, and
both methods have documented validity and sensitivity
with high correlations (r = 0.96) [23].
Left and right hippocampal volumes were measured sepa-
rately. A manual tracing technique was used to delineate
the hippocampus (see Figure 1). Although primarily
measured in the coronal plane, all three views (coronal,
sagittal and axial) were referenced in order to more accu-
rately segment the hippocampus from the surrounding
tissue. Anatomical boundaries were based on the follow-
ing criteria. For the anterior border, separating the hippoc-
ampus from the amygdala was paramount. The
appearance of the mammiliary bodies was used a land-
mark to demarcate roughly where the amygdala starts to
appear as one moves to the anterior of the brain from the
posterior. As slices move anteriorly, amygdala gray matter
begins to extend superior to the hippocampus. With good
resolution, the lateral ventricle can be seen between the
hippocampus and amygdala. Sagittal views aided in this
demarcation. The posterior border was demarcated by the
clearest appearance of the fornix. The lateral border was
defined by the temporal horn of the lateral ventricle and /
or the white matter adjacent to the hippocampal gray mat-
ter. The inferior border was demarcated by the white mat-
ter of the parahippocampal gyrus. Summed areas and slice
thickness were used to calculate volume (right: 20.32 ±
2.85 slices; left: 20.15 ± 2.89 slices [mean ± SD]). Hippoc-
ampal length was calculated by multiplying the number
of slices by the slice thickness.
All measurements were done in a blinded manner by a
trained rater (FPM) in a single batch. Interrater reliabilities
were high (0.98) as were intrarater reliabilities (0.99) for
hippocampal measures. Finished measurements were
transformed into axial and sagittal slices in order to deter-
mine if adequate hippocampal coverage was achieved. By
using all three dimensions of the data set, we feel that we
can accurately measure hippocampal volume by taking
advantage of all three views.
Data analysis
An analysis of covariance (ANCOVA) with age, sex, and
intracranial volume as covariates was used to compare
hippocampal volumes. Unpaired t-tests were used toBMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/2
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examine differences in demographic variables and depres-
sive symptoms. Clinical and developmental correlations
were conducted using Pearson correlations. Two-tailed
test significance was used throughout, with statistical sig-
nificance defined as P < 0.05. All analyses were conducted
using SPSS software (SPSS Inc, Chicago, Ill).
Results
The ANCOVA revealed a significant difference between
MDD and control subjects (F = 8.66, df = 1, 29, P = 0.006).
This was more strongly localized to the left hippocampus
(controls: 3.05 ± 0.11 cm3; MDD: 2.53 ± 0.09 cm3 [mean
± SE]; P = 0.001) than the right hippocampus (controls:
2.88 ± 0.11 cm3; MDD: 2.54 ± 0.12 cm3 [mean ± SE]; P =
0.047) (see Figure 2). Left hippocampal length was also
smaller in adolescent MDD subjects compared to case
matched controls (mean ± SE controls: 3.14 ± 0.09 cm;
MDD: 2.70 ± 0.09 cm [mean ± SE]; t = 4.55, df = 16, P <
0.001). Upon consideration of only the pairs using treat-
ment naïve MDD subjects (14 pairs), the findings
remained, with smaller left hippocampal volumes being
noted in the treatment naïve depressed adolescents (con-
trols: 3.01 ± 0.13 cm3; MDD: 2.48 ± 0.13 cm3 [mean ± SE];
F = 10.83, df = 1, 26, P = 0.003). Age did not correlate with
any measure of the hippocampus in either group.
As expected, MDD subjects were significantly more
depressed than controls (t = 5.29, df = 22, P < 0.001).
CDRS scores did not correlate with hippocampal volumes
in the depressed subjects or the controls. In the depressed
subjects, age of onset was negatively correlated with left
hippocampal volumes (r = -0.59, P = 0.03). However,
duration of illness was positively correlated with left hip-
pocampal volume (r = 0.57, P = 0.04).
Comparable ages were observed in male (16.66 ± 2.06
years [mean ± SD]) and female patients with MDD (16.67
± 1.74 years [mean ± SD]; t = 0.02, df = 15, P = 0.98) indi-
cating that the age ranges in the two sexes were similar.
Age at onset of illness did not differ between male and
female patients (male: 166.17 ± 20.15 months; female:
170.63 ± 27.27 months [mean ± SD]; t = 0.34, df = 12, p
= 0.74). The smaller volume shown in the left hippocam-
pus was more prominent in males (controls: 3.38 ± 0.44
cm3; MDD: 2.65 ± 0.38 cm3 [mean ± SD]; t = 3.51, df = 14,
P = 0.004) than females (controls: 2.76 ± 0.21 cm3; MDD:
2.42 ± 0.37 cm3 [mean ± SD]; t = 2.39, df = 16, P = 0.03).
Discussion
The principal finding of this study is a smaller left hippoc-
ampal volume (by 17 %) in early onset adolescent depres-
sion as compared to age- and sex-matched healthy
controls. In past studies that reported positive findings
regarding decreased hippocampal volumes in depressed
patients, a decrease of similar magnitude was noted (8 –
19 %) [4,5,9,10]. Similar to another study, the smaller
hippocampal volume was more prominent in males than
females [11]. Akin to the trend noted by MacMillan and
colleagues [24], the difference was also more substantial
on the left than the right. Hippocampal size did not corre-
late with age in either group. However, hippocampal size
was correlated negatively with age of onset in the
depressed subjects. This is consistent with Steffens and
others' [8] finding of smaller hippocampal size associated
Sample MRI scans showing the manual tracing technique of the hippocampus Figure 1
Sample MRI scans showing the manual tracing technique of the hippocampus. (a) Full coronal image of the brain. (b) Sagittal 
view of the length of the hippocampal measurement. (c) A section of the image at 2 × magnification showing a close-up of the 
hippocampus in that slice. (d) The hippocampus traced (white outline).BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/2
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Graphs of hippocampal results Figure 2
Graphs of hippocampal results. (a) Left hippocampus in controls and depressed youth and (b) right hippocampus in controls 
and depressed youth.BMC Medicine 2004, 2 http://www.biomedcentral.com/1741-7015/2/2
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with older age of onset. Of special interest is that we noted
a positive correlation with duration of illness and hippoc-
ampal size. This may explain why younger adult studies of
depression (as opposed to middle aged and elderly sam-
ples) have not shown a decrease in hippocampal size [25],
as the difference may be lost during early adulthood.
However, this should be considered speculative and the
correlation should be replicated. As these patients were all
early onset cases, we cannot speculate about the effects of
number of episodes on hippocampal volume.
It is a commonly held hypothesis that cell loss related to
depression in the hippocampus involves glucocorticoids.
Glucocorticoid hypersecretion can lead to cell death in the
hippocampus and may be responsible for the cell loss
noted in this region in a number of neuropsychiatric dis-
orders [26]. Hyperactivity of the hypothalamic-pituitary-
adrenal (HPA) axis is a relatively consistent finding in
adults with MDD, with hypercortisolemia being promi-
nent [27]. This is state-dependent and tends to resolve
with recovery. Hence, the relationship between the
number of days depressed and atrophy in the hippocam-
pus noted by Sheline et al. [5] is logical, as excessive glu-
cocorticoids can lead to increased cell death [26]. In
adolescents with depression, the evidence of cortisol
abnormalities is much less compelling. One study failed
to note any differences in the summary cortisol measures
[28], while two studies noted an increase in cortisol after
sleep onset in depressed adolescents [29,30]. After sleep
onset, cortisol is usually quiescent. It has been hypothe-
sized that it reflects more of a variation in the diurnal var-
iation of cortisol than a robust increase in overall cortisol
activity [29,30]. Mineralcorticoid (MR) receptors appear
to be operative at low cortisol concentrations and may
offer tonic inhibition to the HPA axis during the nadir of
the circadian rhythm [31,32]. As the diurnal activity of the
HPA axis is disrupted in MDD youth, particularly when
cortisol activity is at its lowest [29,30], it may be indicative
of altered MR function, with MRs being found in the amy-
gdala and hippocampus. Classic cortisol hypersecretion is
thought to be rare in depressed children and adolescents
[33]. This is also consistent with our lack of a negative cor-
relation between duration of illness and left hippocampal
volume in depression. However, the reasons behind the
positive correlation are unclear and require replication.
As positive correlations have previously been noted
between hippocampal volume and anxiety in depressed
subjects and controls [24,25], the fact that we did not con-
trol for this may represent a limitation of this study. No
subject had a comorbid anxiety disorder, however, and
unlike the depressed subjects with anxious symptoms
used in the study by Rusch et al. [25], our sample demon-
strated differences in volume when comparing diagnostic
groups. It is also worth noting that Vythilingam and col-
leagues [34] did not find any differences in hippocampal
volume in panic disorder, and hence anxiety may not have
as profound an effect on hippocampal volume as one
would assume.
To our knowledge, this is the first published report regard-
ing hippocampal volume in youth with early onset
depression compared to healthy controls. These conclu-
sions should be considered preliminary, considering the
small sample sizes used. Future directions include the
examination of high-risk for depression subjects, larger
sample sizes and longitudinal studies of illness course.
The use of convergent measures such as tests of working
memory along with the volumetric data would also be of
value. Also, the evaluation of related limbic structures,
such as the amygdala, using MRI is of keen interest.
Conclusions
We have noted smaller left hippocampal volumes in
depressed adolescents compared to healthy age- and sex-
matched controls. This decrease was negatively correlated
with age of onset, indicating a smaller hippocampus in
those experiencing a later age of onset. Left hippocampal
volumes were positively correlated with duration of ill-
ness and may reflect a differential developmental course
incurred by the disorder or an attempt at recovery by the
body.
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